Authors:
Kullmann, F
Hollerbach, S
Lock, G
Holstege, A
Dierks, T
Scholmerich, J
Citation: F. Kullmann et al., Brain electrical activity mapping of EEG for the diagnosis of (sub)clinical hepatic encephalopathy in chronic liver disease, EUR J GASTR, 13(5), 2001, pp. 513-522
Authors:
Kees, F
Holstege, A
Ittner, KP
Zimmermann, M
Lock, G
Scholmerich, J
Grobecker, H
Citation: F. Kees et al., Pharmacokinetic interaction between proton pump inhibitors and roxithromycin in volunteers, ALIM PHARM, 14(4), 2000, pp. 407-412
Citation: H. Messmann et A. Holstege, Endoscopic or surgical treatment of recurrent bleeding ulcer - Reply to J.Danis, Z GASTROENT, 38(5), 2000, pp. XXVIII-XXIX
Authors:
Gmeinwieser, J
Holstege, A
Zirngibl, H
Palitzsch, KD
Hugl, S
Strotzer, M
Feuerbach, S
Scholmerich, J
Citation: J. Gmeinwieser et al., Successful percutaneous treatment of infected necrosis of the body of the pancreas associated with segmental disruption of the main pancreatic duct, GASTROIN EN, 52(3), 2000, pp. 413-415
Authors:
Preclik, G
Grune, G
Leser, HG
Lebherz, J
Heldwein, W
Machka, K
Holstege, A
Kern, WV
Citation: G. Preclik et al., Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy, BR MED J, 319(7214), 1999, pp. 881-884
Authors:
Palitzsch, KD
Hottentrager, B
Schlattmann, K
Frick, E
Holstege, A
Scholmerich, J
Jilg, W
Citation: Kd. Palitzsch et al., Prevalence of antibodies against hepatitis C virus in the adult German population, EUR J GASTR, 11(11), 1999, pp. 1215-1220
Authors:
Eschwege, P
Paradis, V
Conti, M
Holstege, A
Richet, F
Deteve, J
Menager, P
Legrand, A
Jardin, A
Bedossa, P
Benoit, G
Citation: P. Eschwege et al., In situ detection of lipid peroxidation by-products as markers of renal ischemia injuries in rat kidneys, J UROL, 162(2), 1999, pp. 553-557
Authors:
Messmann, H
Knuchel, R
Baumler, W
Holstege, A
Scholmerich, J
Citation: H. Messmann et al., Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinicacid-induced protoporphyrin IX sensitization, GASTROIN EN, 49(1), 1999, pp. 97-101